Yamamoto K - Search Results

1

Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injury.

Torigoe K, Obata Y, Torigoe M, Oka S, Yamamoto K, Koji T, Ueda H, Mukae H, Nishino T. Torigoe K, et al. Among authors: yamamoto k. Clin Exp Nephrol. 2020 May;24(5):411-419. doi: 10.1007/s10157-019-01843-1. Epub 2020 Jan 7. Clin Exp Nephrol. 2020. PMID: 31912273

2

An inhibitor of Krüppel-like factor 5 suppresses peritoneal fibrosis in mice.

Muta K, Nakazawa Y, Obata Y, Inoue H, Torigoe K, Nakazawa M, Abe K, Furusu A, Miyazaki M, Yamamoto K, Koji T, Nishino T. Muta K, et al. Among authors: yamamoto k. Perit Dial Int. 2021 Jul;41(4):394-403. doi: 10.1177/0896860820981322. Epub 2021 Feb 1. Perit Dial Int. 2021. PMID: 33522431

3

Compounds in cigarette smoke induce EGR1 expression via the AHR, resulting in apoptosis and COPD.

Hattori N, Nakagawa T, Yoneda M, Hayashida H, Nakagawa K, Yamamoto K, Htun MW, Shibata Y, Koji T, Ito T. Hattori N, et al. Among authors: yamamoto k. J Biochem. 2022 Dec 5;172(6):365-376. doi: 10.1093/jb/mvac077. J Biochem. 2022. PMID: 36200927

4

Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.

Ichinose K, Ushigusa T, Nishino A, Nakashima Y, Suzuki T, Horai Y, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Arima K, Nakamura H, Obata Y, Yamamoto K, Origuchi T, Nishino T, Kawakami A, Tsokos GC. Ichinose K, et al. Among authors: yamamoto k. Arthritis Rheumatol. 2016 Apr;68(4):944-52. doi: 10.1002/art.39499. Arthritis Rheumatol. 2016. PMID: 26636664 Free PMC article.

5

Role of cyclophilin B in activation of interferon regulatory factor-3.

Obata Y, Yamamoto K, Miyazaki M, Shimotohno K, Kohno S, Matsuyama T. Obata Y, et al. Among authors: yamamoto k. J Biol Chem. 2005 May 6;280(18):18355-60. doi: 10.1074/jbc.M501684200. Epub 2005 Mar 10. J Biol Chem. 2005. PMID: 15764595 Free article.

6

Expression of the c-Met proto-oncogene and its possible involvement in liver invasion in adult T-cell leukemia.

Imaizumi Y, Murota H, Kanda S, Hishikawa Y, Koji T, Taguchi T, Tanaka Y, Yamada Y, Ikeda S, Kohno T, Yamamoto K, Mori N, Tomonaga M, Matsuyama T. Imaizumi Y, et al. Among authors: yamamoto k. Clin Cancer Res. 2003 Jan;9(1):181-7. Clin Cancer Res. 2003. PMID: 12538467

7

Active repression of IFN regulatory factor-1-mediated transactivation by IFN regulatory factor-4.

Yoshida K, Yamamoto K, Kohno T, Hironaka N, Yasui K, Kojima C, Mukae H, Kadota J, Suzuki S, Honma K, Kohno S, Matsuyama T. Yoshida K, et al. Among authors: yamamoto k. Int Immunol. 2005 Nov;17(11):1463-71. doi: 10.1093/intimm/dxh324. Epub 2005 Sep 19. Int Immunol. 2005. PMID: 16172134

8

Interferon regulatory factor-4 activates IL-2 and IL-4 promoters in cooperation with c-Rel.

Shindo H, Yasui K, Yamamoto K, Honma K, Yui K, Kohno T, Ma Y, Chua KJ, Kubo Y, Aihara H, Ito T, Nagayasu T, Matsuyama T, Hayashi H. Shindo H, et al. Among authors: yamamoto k. Cytokine. 2011 Dec;56(3):564-72. doi: 10.1016/j.cyto.2011.08.014. Epub 2011 Sep 3. Cytokine. 2011. PMID: 21890374

9

Mechanistic aspects of mammalian cell size control.

Yamamoto K, Mak TW. Yamamoto K, et al. Dev Growth Differ. 2017 Jan;59(1):33-40. doi: 10.1111/dgd.12334. Epub 2016 Dec 30. Dev Growth Differ. 2017. PMID: 28035665 Review.

10

Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.

Murota H, Hamasaki Y, Nakashima T, Yamamoto K, Katayama I, Matsuyama T. Murota H, et al. Among authors: yamamoto k. Arthritis Rheum. 2003 Apr;48(4):1117-25. doi: 10.1002/art.10896. Arthritis Rheum. 2003. PMID: 12687556 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,280 results

Search Page